These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13149617)

  • 21. Fibrinolytic (plasmin) therapy of experimental coronary thrombi with alteration of the evolution of myocardial infarction.
    RUEGSEGGER P; NYDICK I; HUTTER RC; FREIMAN AH; BANG NU; CLIFFTON EE; LADUE JS
    Circulation; 1959 Jan; 19(1):7-13. PubMed ID: 13619015
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of human plasmin on the toxic effects and growth of blood borne metastatis of the Brown-Pearce carcinoma and the V2 carcinoma of rabbit.
    CLIFFTON EE; GROSSI CE
    Cancer; 1956; 9(6):1147-52. PubMed ID: 13383444
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
    Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
    Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the influence of the administration of trypsin or plasmin on the plasma fibrinogen content in rabbits].
    MORIYA M
    Nihon Seirigaku Zasshi; 1961 Mar; 23():147-60. PubMed ID: 13772702
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibrinolysis and hyphema. The effect of thrombolysin and Kabikinas on clotted blood in camera anterior of the eye in rabbits.
    HORVEN I
    Acta Ophthalmol (Copenh); 1962; 40():320-6. PubMed ID: 14449118
    [No Abstract]   [Full Text] [Related]  

  • 26. Cross-species pharmacologic evaluation of plasmin as a direct-acting thrombolytic agent: ex vivo evaluation for large animal model development.
    Landskroner K; Olson N; Jesmok G
    J Vasc Interv Radiol; 2005 Mar; 16(3):369-77. PubMed ID: 15758133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombolysis in dogs with human fibrinolysin.
    BOYLES PW
    J Lab Clin Med; 1959 Oct; 54():551-5. PubMed ID: 13803600
    [No Abstract]   [Full Text] [Related]  

  • 28. [The action of modified plasmin on the lysis of experimental thrombi].
    Kizim AI; Pokrovskaia TN
    Vrach Delo; 1990 May; (5):39-40. PubMed ID: 1697714
    [No Abstract]   [Full Text] [Related]  

  • 29. Lysis of cerebrovascular blood clots.
    MEYER JS
    N Y State J Med; 1962 Dec; 62():3750-3. PubMed ID: 13935287
    [No Abstract]   [Full Text] [Related]  

  • 30. Fibrinolysin treatment of induced venous thrombosis in the dog.
    WILSON JS
    Surgery; 1960 Sep; 48():469-80. PubMed ID: 13845091
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of soluble and immobilized plasmin on fibrinogen and platelets.
    Senatore F; Shankar H; Ho CH; Avantsa S; Allon M; Posteraro R
    Thromb Haemost; 1990 Nov; 64(3):445-9. PubMed ID: 2151408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assay procedure for the quantitative determination of clot lysis activity.
    BAUMGARTEN W; CIMINERA JL; COLE RB
    Vox Sang; 1960 Sep; 5():416-24. PubMed ID: 13688014
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of heparin, plasmin, dextran and low-molecular-weight dextran on electrically induced thromboses.
    Flemma RJ; Acinapura AJ; Silver D; Anlyan WG
    Am Surg; 1966 Jan; 32(1):17-9. PubMed ID: 4221357
    [No Abstract]   [Full Text] [Related]  

  • 34. INTRAVASCULAR COAGULATION AND FIBRINOLYSIN THERAPY IN ENDOTOXIN SHOCK.
    CAVANAGH D; ALBORES EA
    Am J Obstet Gynecol; 1965 Jul; 92():856-64. PubMed ID: 14310039
    [No Abstract]   [Full Text] [Related]  

  • 35. [The role of the active center of the enzyme in the triggering mechanism of the compensatory reaction to plasmin].
    Kalishevskaia TM; Golubeva MG; Aĭsina RB; Popova GIu; Bashkov GV
    Biull Eksp Biol Med; 1989 Mar; 107(3):260-4. PubMed ID: 2523741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmin lysis of fibrinogen and fibrin and the antigenic properties of their degradation products.
    Ekert H; Muntz RH
    Br J Haematol; 1972 Jan; 22(1):103-10. PubMed ID: 4258329
    [No Abstract]   [Full Text] [Related]  

  • 37. The blood kinin-forming system activated by plasmin.
    Buluk K; Czokalo M; Malofiejew M
    Arch Int Physiol Biochim; 1970 Dec; 78(5):961-9. PubMed ID: 4101927
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lysis of thrombi and emboli by means of streptokinase. I. Activation of fibrinolysis, mechanism of plasmin activity, indications and contra-indications, treatment principles].
    Janda R; Cencora A; Uzieblo W
    Przegl Lek; 1969; 25(10):701-5. PubMed ID: 4242965
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of heparin, plasmin, dextran, and low molecular dextran on bioelectrically induced thromboses.
    Flemma RJ; Silver D; Anlyan WG
    Surg Forum; 1965; 16():123-4. PubMed ID: 4220793
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of fibrinolysin in experimental thrombosis].
    ANDREENKO GV; CHAZOV EI
    Vopr Med Khim; 1962; 8():47-52. PubMed ID: 13861409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.